Literature DB >> 14552909

Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235.

X G Huang1, B K Yee, S Nag, S T H Chan, F Tang.   

Abstract

Human presenilin-1 (PS1) mutations are associated with the incidence of familial Alzheimer's disease. The present study evaluated the behavioral and neurochemical effects of the L235P mutation (substitution of leucine by proline at codon 235) of the human PS1 gene, which has been linked to a form of early-onset Alzheimer's disease. Except for a significant increase in the production of beta-amyloid-42, the mutant mice did not show any overt signs of Alzheimer-like neuropathology in the form of plaque formation, changes in choline acetyltransferase activity, or somatostatin content in the brain. Cognitive assays indicated that the mutation did not affect the acquisition or reversal of a spatial reference memory task in the water maze or performance on a spatial working memory task. In contrast, L235P PS1 transgenic mice exhibited a significant impairment in a test of spontaneous object recognition. This dissociation is suggestive of a preferential impairment of the extrahippocampal memory system and is consistent with what has been reported in another pathological mutation (substitution of leucine by valine at codon 286) of the PS1 gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14552909     DOI: 10.1016/s0014-4886(03)00242-5

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  11 in total

Review 1.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

Review 2.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

3.  Increased phosphorylation of tau and synaptic protein loss in the aged transgenic mice expressing familiar Alzheimer's disease-linked presenilin 1 mutation.

Authors:  Xifei Yang; Ying Yang; Jianjun Liu; Geng Li; Edward Yang
Journal:  Neurochem Res       Date:  2011-08-13       Impact factor: 3.996

4.  Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia.

Authors:  Jonathan L Brigman; Carolyn Graybeal; Andrew Holmes
Journal:  Front Neurosci       Date:  2010-05-15       Impact factor: 4.677

Review 5.  Presenilin transgenic mice as models of Alzheimer's disease.

Authors:  Gregory A Elder; Miguel A Gama Sosa; Rita De Gasperi; Dara L Dickstein; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2009-11-18       Impact factor: 3.270

6.  Hyperphosphorylation and accumulation of neurofilament proteins in transgenic mice with Alzheimer presenilin 1 mutation.

Authors:  Xifei Yang; Ying Yang; Yougen Luo; Geng Li; Jianzhi Wang; Edward S Yang
Journal:  Cell Mol Neurobiol       Date:  2009-01-10       Impact factor: 5.046

7.  Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice.

Authors:  Jahn N O'Neil; Peter R Mouton; Yousef Tizabi; Mary Ann Ottinger; De-Liang Lei; Donald K Ingram; Kebreten F Manaye
Journal:  J Chem Neuroanat       Date:  2007-05-31       Impact factor: 3.052

8.  Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.

Authors:  Xifei Yang; Ying Yang; Geng Li; Jianzhi Wang; Edward S Yang
Journal:  J Mol Neurosci       Date:  2008-01-05       Impact factor: 3.444

Review 9.  Intracellular Calcium Dysregulation by the Alzheimer's Disease-Linked Protein Presenilin 2.

Authors:  Luisa Galla; Nelly Redolfi; Tullio Pozzan; Paola Pizzo; Elisa Greotti
Journal:  Int J Mol Sci       Date:  2020-01-24       Impact factor: 5.923

10.  Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.

Authors:  Anna Ochalek; Balázs Mihalik; Hasan X Avci; Abinaya Chandrasekaran; Annamária Téglási; István Bock; Maria Lo Giudice; Zsuzsanna Táncos; Kinga Molnár; Lajos László; Jørgen E Nielsen; Bjørn Holst; Kristine Freude; Poul Hyttel; Julianna Kobolák; András Dinnyés
Journal:  Alzheimers Res Ther       Date:  2017-12-01       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.